1.45
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTXR Giù?
Forum
Previsione
Frazionamento azionario
Citius Pharmaceuticals Inc Borsa (CTXR) Ultime notizie
Custom watchlist performance reports with Citius Pharmaceuticals Inc.Market Movers & AI Driven Stock Reports - newser.com
Will Citius Pharmaceuticals Inc. stock split attract more investorsJuly 2025 Summary & Consistent Return Strategy Ideas - Trung tâm Dự báo KTTV quốc gia
Valuation Update: Will Citius Pharmaceuticals Inc. stock split attract more investors2025 Big Picture & Community Verified Trade Alerts - Trung tâm Dự báo KTTV quốc gia
3 Conferences in Oct 2025 — Citius Pharmaceuticals and Citius Oncology to Meet Investors - Stock Titan
Is Citius Pharmaceuticals Inc. (47N0) stock undervalued at current priceBull Run & Weekly High Potential Stock Alerts - newser.com
Has Citius Pharmaceuticals Inc. found a price floorQuarterly Trade Summary & Daily Technical Stock Forecast Reports - newser.com
Is Citius Pharmaceuticals Inc. stock positioned for long term growthTrade Entry Summary & Daily Growth Stock Investment Tips - newser.com
Can Citius Pharmaceuticals Inc. (47N0) stock sustain breakout momentumMarket Performance Summary & Daily Entry Point Alerts - newser.com
Citius Oncology and EVERSANA sign exclusive agreement for Q4 2025 launch of LYMPHIR - ROI-NJ
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR - Nasdaq
Citius Pharmaceuticals (NASDAQ: CTXR) Eyes $400M Market Opportunity with LYMPHIR Launch - openPR.com
Is Citius Pharmaceuticals Inc. (47N0) stock considered safe haven2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Why Citius Pharmaceuticals Inc. stock could outperform in 2025Trade Volume Report & AI Driven Stock Reports - newser.com
Should you wait for a breakout in Citius Pharmaceuticals Inc.Weekly Stock Recap & Technical Buy Zone Confirmations - newser.com
How to manage a losing position in Citius Pharmaceuticals Inc.Rate Cut & Real-Time Volume Analysis Alerts - newser.com
How currency fluctuations impact Citius Pharmaceuticals Inc. stockJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
What earnings revisions data tells us about Citius Pharmaceuticals Inc.Global Markets & Smart Swing Trading Alerts - newser.com
Short interest data insights for Citius Pharmaceuticals Inc.July 2025 Rallies & Long Hold Capital Preservation Plans - newser.com
Forecasting Citius Pharmaceuticals Inc. price range with options dataJobs Report & Weekly Consistent Profit Watchlists - newser.com
Is Citius Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Retail & Risk Managed Investment Signals - newser.com
Citius in talks over Lymphir access in global markets - The Pharma Letter
Is Citius Pharmaceuticals Inc 47N0 a good long term investmentEarnings Growth Projections & High Return Capital Strategies - earlytimes.in
Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe - GuruFocus
Published on: 2025-10-06 05:51:11 - newser.com
How strong dollar benefits Citius Pharmaceuticals Inc. (47N0) stock2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
Will Citius Pharmaceuticals Inc. (47N0) stock sustain bullish trend into 2025July 2025 Intraday Action & High Yield Stock Recommendations - newser.com
Can Citius Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 Outlook & Comprehensive Market Scan Reports - newser.com
How Citius Pharmaceuticals Inc. (47N0) stock reacts to Fed tighteningTrade Volume Summary & Precise Buy Zone Identification - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):